Stelmakh Edward
SEC CIK 1887046 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OPRX | OptimizeRx Corp | Chief Fin, Strat Off | 121.8K | $46.3K | $18.8K | 28 | 2022-08-15 | 2026-08-21 |
Most active insiders at OPRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Silvestro Stephen L | CEO | — | $30.4K |
| 2 | Stelmakh Edward | Chief Fin, Strat Off | — | $18.8K |
| 3 | Presti Mariyamma Varghese | Dir | — | — |
| 4 | Merrell Brendan W. | COO | — | — |
| 5 | D'Silva Andrew J. | Chief Business Off | — | — |
| 6 | Greco Theresa | Chief Commercial Off | — | — |
| 7 | Besch Doug | Chief Product, Tech Off | — | — |
| 8 | Odence-Ford Marion | Chief Legal, Admin Off | — | — |
| 9 | Lang James Paul | Dir | — | — |
| 10 | Vos Ellen O'Connor | Dir | — | — |
Transactions 28
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-24 15:11 | 2026-08-21 | OPRX | OptimizeRx Corp | Stelmakh Edward | Chief Fin, Strat Off | F - Tax | $7.71 | -1,381 | 121.8K | -1% | -$10.6K | |
| DA | 2025-12-23 | 2025-12-19 | OPRX | OptimizeRx Corp | Stelmakh Edward | Chief Fin, Strat Off | M - OptEx | $0.00 | +5,237 | 128.2K | +4% | $0 |
| DA | 2025-12-23 | 2025-12-19 | OPRX | OptimizeRx Corp | Stelmakh Edward | Chief Fin, Strat Off | F - Tax | $13.51 | -1,388 | 126.8K | -1% | -$18.8K |
| 2025-12-23 | 2025-12-23 | OPRX | OptimizeRx Corp | Stelmakh Edward | Chief Fin, Strat Off | F - Tax | $12.74 | -3,658 | 123.2K | -3% | -$46.6K | |
| D | 2025-12-22 | 2025-12-19 | OPRX | OptimizeRx Corp | Stelmakh Edward | Chief Fin, Strat Off | S - Sale+OE | $13.51 | -1,388 | 126.8K | -1% | -$18.8K |
| D | 2025-12-22 | 2025-12-19 | OPRX | OptimizeRx Corp | Stelmakh Edward | Chief Fin, Strat Off | M - OptEx | $0.00 | +5,237 | 128.2K | +4% | $0 |
| D | 2025-10-07 | 2025-10-03 | OPRX | OptimizeRx Corp | Stelmakh Edward | Chief Fin, Strat Off | M - OptEx | $0.00 | +16.6K | 127.4K | +15% | $0 |
| D | 2025-10-07 | 2025-10-03 | OPRX | OptimizeRx Corp | Stelmakh Edward | Chief Fin, Strat Off | F - Tax | $18.75 | -4,406 | 123.0K | -3% | -$82.6K |
| D | 2025-08-25 | 2025-08-21 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | A - Grant | $0.00 | +15.6K | 110.8K | +16% | $0 |
| 2025-02-20 | 2025-02-15 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | F - Tax | $6.64 | -2,156 | 95.1K | -2% | -$14.3K | |
| A | 2024-12-27 | 2024-02-15 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | A - Grant | — | 0 | 33.4K | New | — |
| D | 2024-12-27 | 2024-12-23 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | A - Grant | $0.00 | +41.4K | 97.3K | +74% | $0 |
| D | 2024-12-20 | 2024-12-19 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | M - OptEx | $0.00 | +5,237 | 38.6K | +16% | $0 |
| D | 2024-12-20 | 2024-12-19 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | F - Tax | $4.75 | -1,316 | 37.3K | -3% | -$6,251 |
| D | 2024-10-15 | 2024-10-11 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | M - OptEx | $0.00 | +8,222 | 35.4K | +30% | $0 |
| D | 2024-10-15 | 2024-10-11 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | F - Tax | $6.63 | -2,066 | 33.4K | -6% | -$13.7K |
| D | 2024-10-07 | 2024-10-03 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | F - Tax | $7.83 | -4,177 | 27.2K | -13% | -$32.7K |
| D | 2024-10-07 | 2024-10-03 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | M - OptEx | $0.00 | +16.6K | 31.4K | +113% | $0 |
| 2024-04-24 | 2024-02-15 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | A - Grant | $0.00 | +7,083 | 14.8K | +92% | $0 | |
| A | 2024-04-22 | 2022-10-11 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | F - Tax | $15.17 | -3,539 | 7,682 | -32% | -$53.7K |
| A | 2024-04-22 | 2023-10-11 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | M - OptEx | $0.00 | +8,221 | 28.0K | +41% | $0 |
| DM | 2023-10-12 | 2022-10-11+ | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | M - OptEx | $0.00 | +14.4K | 25.4K | +130% | $0 |
| D | 2023-10-12 | 2023-10-11 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | F - Tax | $7.15 | -2,066 | 29.5K | -7% | -$14.8K |
| D | 2023-10-06 | 2023-10-03 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | F - Tax | $7.06 | -4,117 | 17.2K | -19% | -$29.1K |
| D | 2023-10-06 | 2023-10-03 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | M - OptEx | $0.00 | +16.7K | 21.3K | +356% | $0 |
| D | 2023-03-30 | 2022-10-11 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | F - Tax | $15.17 | -6,539 | 4,682 | -58% | -$99.2K |
| D | 2023-03-30 | 2022-10-11 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | M - OptEx | $0.00 | +8,221 | 11.2K | +274% | $0 |
| 2022-08-17 | 2022-08-15 | OPRX | OptimizeRx Corp | Stelmakh Edward | CFO, COO | P - Purchase | $15.43 | +3,000 | 3,000 | New | +$46.3K |
Purchase Sale Sale after option exercise All abbreviations